NutriBand (NTRB) Inventory Average (2016 - 2026)
NutriBand (NTRB) posted Inventory Average of $119740.5 for Q2 2026, down 5.71% sequentially from $126992.5 in Q1 2026, and down 43.96% YoY from $213682.5 in Q2 2025.
NutriBand (NTRB) Inventory Average (2016 - 2026) Analysis & Trends
NutriBand has reported Inventory Average for 9 years, with the latest figure at $119740.5 in Q2 2026.
- Quarterly Inventory Average fell 43.96% year-over-year to $119740.5 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $119740.5 (down 43.96% YoY) and the FY2026 annual result came in at $165014.0, down 13.3% from the prior year.
- Inventory Average fell to $119740.5 in Q2 2026 per NTRB's latest filing, from $126992.5 in the prior quarter.
- Over five years, Inventory Average peaked at $213682.5 in Q2 2025 and troughed at $119740.5 in Q2 2026.
- A 5-year average of $167755.2 and a median of $170416.0 in 2023 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2026: Inventory Average jumped 178.72% in 2022, then sank 43.96% in 2026.
- Over 5 years, Inventory Average stood at $173076.5 in 2022, then decreased by 4.22% to $165781.0 in 2023, then gained by 18.28% to $196079.5 in 2024, then plunged by 30.12% to $137014.5 in 2025, then declined by 12.61% to $119740.5 in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $119740.5, $126992.5, and $137014.5 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 | 119,740.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 119,740.50 |
| Jan 31, 2026 | 126,992.50 |
| Oct 31, 2025 | 137,014.50 |
| Jul 31, 2025 | 176,677.50 |
| Apr 30, 2025 | 213,682.50 |
| Jan 31, 2025 | 190,170.00 |
| Oct 31, 2024 | 196,079.50 |
| Jul 31, 2024 | 196,182.50 |
| Apr 30, 2024 | 168,555.00 |
| Jan 31, 2024 | 171,623.00 |
| Oct 31, 2023 | 165,781.00 |
| Jul 31, 2023 | 169,209.00 |
| Apr 30, 2023 | 205,416.00 |
| Jan 31, 2023 | 206,829.00 |
| Oct 31, 2022 | 173,076.50 |
| Jul 31, 2022 | 144,681.50 |
| Apr 30, 2022 | 129,590.50 |
| Jan 31, 2022 | 128,292.50 |
| Oct 31, 2021 | 98,768.50 |
| Jul 31, 2021 | 81,433.00 |